Original Article

You have full text access to this OnlineOpen article

Prognostic significance of the lymphocyte-to-neutrophil ratio in percutaneous fine-needle aspiration biopsy specimens of advanced nonsmall cell lung carcinoma

  1. Yasuharu Nakahara M.D.1,†,*,
  2. Yoshiro Mochiduki M.D.2,
  3. Yoshihiro Miyamoto M.D.3,
  4. Yukiko Nakahara M.D.2,
  5. Yoshitaka Katsura Ph.D.4

Article first published online: 26 JUL 2005

DOI: 10.1002/cncr.21290

Issue

Cancer

Cancer

Volume 104, Issue 6, pages 1271–1280, 15 September 2005

Additional Information

How to Cite

Nakahara, Y., Mochiduki, Y., Miyamoto, Y., Nakahara, Y. and Katsura, Y. (2005), Prognostic significance of the lymphocyte-to-neutrophil ratio in percutaneous fine-needle aspiration biopsy specimens of advanced nonsmall cell lung carcinoma. Cancer, 104: 1271–1280. doi: 10.1002/cncr.21290

Author Information

  1. 1

    Department of Respiratory Medicine, National Hospital Organization Himeji Medical Center, Himeji-city, Japan

  2. 2

    Department of General Medicine, National Hospital Organization Himeji Medical Center, Himeji-city, Japan

  3. 3

    Department of Respiratory Surgery, National Hospital Organization Himeji Medical Center, Himeji-city, Japan

  4. 4

    Department of Pathology, National Hospital Organization Himeji Medical Center, Himeji-city, Japan

  1. †

    Fax: (011) 81-792-23-8310

*Department of Respiratory Medicine, National Hospital Organization Himeji Medical Center, 68 Honmachi, Himeji-city 670-8520, Japan

Publication History

  1. Issue published online: 31 AUG 2005
  2. Article first published online: 26 JUL 2005
  3. Manuscript Accepted: 25 APR 2005
  4. Manuscript Revised: 2 APR 2005
  5. Manuscript Received: 1 FEB 2005

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (222K)

REFERENCES

  • 1
    Nacopoulou L, Azaris P, Papacharalampous N, Davaris P. Prognostic significance of histologic host response in cancer of the large bowel. Cancer. 1981; 47: 930–936.
    Direct Link:
  • 2
    An T, Sood U, Pietruk T, Cummings G, Hashimoto K, Crissman JD. In situ quantitation of inflammatory mononuclear cells in ductal infiltrating breast carcinoma. Relation to prognostic parameters. Am J Pathol. 1987; 128: 52–60.
  • 3
    Lipponen PK, Eskelinen MJ, Jauhiainen K, Harju E, Terho R. Tumour infiltrating lymphocytes as an independent prognostic factor in transitional cell bladder cancer. Eur J Cancer. 1992; 29A: 69–75.
  • 4
    Setala LP, Kosma VM, Marin S, et al. Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration. Br J Cancer. 1996; 74: 766–772.
  • 5
    Lee TK, Horner RD, Silverman JF, Chen YH, Jenny C, Scarantino CW. Morphometric and morphologic evaluations in stage III non-small cell lung cancers. Prognostic significance of quantitative assessment of infiltrating lymphoid cells. Cancer. 1989; 63: 309–316.
    Direct Link:
  • 6
    Di Giorgio A, Mingazzini P, Sammartino P, Canavese A, Arnone P, Scarpini M. Host defense and survival in patients with lung carcinoma. Cancer. 2000; 89: 2038–2045.
    Direct Link:
  • 7
    Johnson SK, Kerr KM, Chapman AD, et al. Immune cell infiltrates and prognosis in primary carcinoma of the lung. Lung Cancer. 2000; 27: 27–35.
  • 8
    Eerola AK, Soini Y, Paakko P. A high number of tumor-infiltrating lymphocytes are associated with a small tumor size, low tumor stage, and a favorable prognosis in operated small cell lung carcinoma. Clin Cancer Res. 2000; 6: 1875–1881.
  • 9
    SobinLH, WittekindC, editors. TNM classification of malignant tumors, 5th ed. New York: John Wiley & Sons, 1997.
  • 10
    Black MM, Speer FD, Opler SR. Structural representations of tumor-host relationships in mammary carcinoma. Biologic and prognostic significance. Am J Clin Pathol. 1956; 26: 250–265.
  • 11
    Wallgren A, Zajicek J. The prognostic value of the aspiration biopsy smear in mammary carcinoma. Acta Cytol. 1976; 20: 479–485.
  • 12
    Feld R, Arriagada R, Ball DL, Mattson K, Sørensen JB. Prognostic factors in non-small cell lung cancer: a consensus report. Lung Cancer. 1991; 7: 3–5.
  • 13
    Baak JP, Van Dop H, Kurver PH, Hermans J. The value of morphometry to classic prognosticators in breast cancer. Cancer. 1985; 56: 374–382.
    Direct Link:
  • 14
    Crissman JD, Liu WY, Gluckman JL, Cummings G. Prognostic value of histopathologic parameters in squamous cell carcinoma of the oropharynx. Cancer. 1984; 54: 2995–3001.
    Direct Link:
  • 15
    James RD, Davey AT. Mitotic index in carcinoma of the lung. Lancet. 1979; 2: 852.
  • 16
    Gerstl B, Wong S, Yesner R. Quantitative microscopy of epidermoid lung carcinoma: correlation with survival time. J Natl Cancer Inst. 1976; 56: 463–469.
  • 17
    Bernardi Fdel C, Capelozzi VL, Takagaki TY, Younes RN, Saldiva PH. Usefulness of morphometric evaluation of histopathologic slides in predicting long-term outcome of patients with squamous cell carcinoma of the lung. A preliminary report. Chest. 1995; 107: 614–620.
  • 18
    Daniels JM, Eerenberg JP, Rijna H, et al. Mitotic index does not predict prognosis in stage IA non-small cell lung cancer. Lung Cancer. 2002; 38: 163–167.
  • 19
    Cagle PT, Langston C, Fraire AE, Roggli VL, Greenberg SD. Absence of correlation between nuclear morphometry and survival in stage I non-small cell lung carcinoma. Cancer. 1992; 69: 2454–2457.
    Direct Link:
  • 20
    Weiss W. The mitotic index in bronchogenic carcinoma. Am Rev Respir Dis. 1971; 104: 536–543.
  • 21
    Setälä LP, Kosma VM, Marin S, et al. Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration. Br J Cancer. 1996; 74: 766–772.
  • 22
    Shibusa T, Shijubo N, Abe S. Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma. Clin Cancer Res. 1998; 4: 1483–1487.
  • 23
    Fontanini G, Lucchi M, Vignati S, et al. Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study. J Natl Cancer Inst. 1997; 89: 881–886.
  • 24
    Watanabe S, Sato Y, Kodama T, Shimosato Y. Immunohistochemical study with monoclonal antibodies on immune response in human lung cancers. Cancer Res. 1983; 43: 5883–5889.
  • 25
    Berger RL, Dargan EL, Huang BL. Dissemination of cancer cells by needle biopsy of the lung. J Thorac Cardiovasc Surg. 1972; 63: 430–432.
  • 26
    Seyfer AE, Walsh DS, Graeber GM, Nuno IN, Eliasson AH. Chest wall implantation of lung cancer after thin-needle aspiration biopsy. Ann Thorac Surg. 1989; 48: 284–286.
  • 27
    Kara M, Alver G, Sak SD, Kavukçu S. Implantation metastasis caused by fine needle aspiration biopsy following curative resection of stage IB non-small cell lung cancer. Eur J Cardiothorac Surg. 2001; 20: 868–870.
  • 28
    Kjellberg SI, Dresler CM, Goldberg M. Pleural cytologies in lung cancer without pleural effusions. Ann Thorac Surg. 1997; 64: 941–944.
  • 29
    Sawabata N, Maeda H, Ohta M, Hayakawa M. Operable non-small cell lung cancer diagnosed by transpleural techniques: do they affect relapse and prognosis? Chest. 2001; 120: 1595–1598.
View Full Article (HTML) Get PDF (222K)